Connecticut program
Fair coverage for cancer pills (oral anticancer parity)
A Connecticut rule requiring oral anticancer medicine coverage on terms no less favorable than intravenous treatment.
What it is
A Connecticut rule requiring oral anticancer medicine coverage on terms no less favorable than intravenous treatment.
A chemo pill is billed under the pharmacy part of a plan, so its cost can surprise you. Connecticut's rule says the pill cannot get worse coverage than the same treatment by drip. It applies to plans Connecticut regulates; a plan where the employer pays its own claims is usually outside it, and HR can say which yours is.
Eligibility rules
- The rule applies to Connecticut-issued insured plans, with no income test.
- The CID rule applies to qualifying policies issued, renewed, amended or continued from January 1, 2011, covering both oral and intravenous treatment. The drug must be prescribed to kill or slow cancer cells.
What you get
- Coverage terms for oral anticancer medicine no less favorable than intravenous anticancer treatment.
What the help covers
- For a Connecticut-regulated policy covered by the rule, oral anticancer medicine must use a cost-sharing basis no less favorable than covered intravenous anticancer treatment. This does not guarantee the same price for a pill and an infusion, formulary coverage or a fixed dollar cap.
If you decide to apply
- Ask the pharmacy or hospital billing team to compare the oral medicine’s coverage with the plan’s infusion terms.
- Have the medicine name, pharmacy receipt and plan documents ready.
- Ask the Insurance Department about a possible parity problem if the comparison raises one.
The plan; the Insurance Department takes complaints. 860-297-3900 · Official page ↗
After you apply
- The plan can review the pharmacy charge and explain its basis. The Insurance Department handles complaints at 860-297-3900.
Good to know
This rule does not mean every cancer pill is free. Self-funded employer plans are generally outside state insurance rules.
Other details
- A family’s particular medicines and plan terms determine whether this issue arises. A cancer diagnosis does not establish that oral treatment is prescribed.
- Since July 2026, if you pay cash for a medicine because it is cheaper than the plan's price, the plan may have to count that payment toward your deductible; keep the receipt and ask.
Official sources
“If our child needs cancer pills, are the pharmacy charges consistent with the state parity rule? Could you explain the limits and help request a correction if something is wrong?”
Why I’m asking: I want to understand whether a high cancer-medicine bill reflects the coverage rules.
More background and detailed requirements
Additional program information and published rules
Who does what
The three parts, side by side. The agency decides; nobody on this page does.
You
Discuss the benefit and tradeoffs with the social worker. Ask the pharmacy or hospital billing team to compare the oral medicine’s coverage with the plan’s infusion terms. Have the medicine name, pharmacy receipt and plan documents ready. Ask the Insurance Department about a possible parity problem if the comparison raises one.
Your social worker
For a Connecticut-regulated policy covered by the rule, oral anticancer medicine must use a cost-sharing basis no less favorable than covered intravenous anticancer treatment. This does not guarantee the same price for a pill and an infusion, formulary coverage or a fixed dollar cap.
The care team
The pharmacist confirms the drug is an anticancer medication.
- Who decides
- The plan; the Insurance Department takes a complaint.
- Ask the care team
- “If our child needs cancer pills, are the pharmacy charges consistent with the state parity rule? Could you explain the limits and help request a correction if something is wrong?”
How to apply
First step: Your social worker can help you discuss this route and prepare the request if it fits. Ask the pharmacy or hospital billing team to compare the oral medicine’s coverage with the plan’s infusion terms.
- Ask the pharmacy or hospital billing team to compare the oral medicine’s coverage with the plan’s infusion terms.
- Have the medicine name, pharmacy receipt and plan documents ready.
- Ask the Insurance Department about a possible parity problem if the comparison raises one.
Official application / program page ↗
Where it starts: The pharmacist and social worker can compare the covered oral and intravenous cost-sharing terms and ask CID about a possible mismatch.
What to gather
- The pharmacy receipt
- The plan’s oral and intravenous anticancer cost-sharing terms
How long: Not applicable: it is a rule the plan has to follow.
What a yes looks like
The plan explains or corrects the charge under the required cost-sharing comparison.
What a no looks like, and the next move
Ask the plan in writing which rules it follows, then call the Insurance Department on 860-297-3900.
Watch out
- The actual prescription and coverage terms determine whether a parity issue arises.
- Connecticut-regulated insured policies are the state route; most self-funded employer plans are outside it.
- Parity does not itself promise a fixed prescription cap or identical pill-and-infusion price.
Dates that change this
2026-09-11: The CID parity rule applies to qualifying policies issued, renewed, amended or continued from January 1, 2011. CID confirms current policy scope and any additional cost protection; parity alone does not promise a fixed per-fill cap.
The numbers and the rules
The arcane layer, kept on purpose. Checked September 11, 2026.
What it is worth
Qualifying oral anticancer treatment uses a cost-sharing basis no less favorable than covered intravenous anticancer treatment.
Legal protection: For a Connecticut-regulated policy covered by the rule, oral anticancer medicine must use a cost-sharing basis no less favorable than covered intravenous anticancer treatment. This does not guarantee the same price for a pill and an infusion, formulary coverage or a fixed dollar cap.
What it costs the family: Free to invoke.
The eligibility facts, as published
- Age
- any
- Income
- no income test
- Insurance status condition
- Connecticut-issued insured plans; self-funded plans generally outside
- Residency
- Connecticut
- Processing standard
- not applicable
Decisions this site cannot make: The plan applies it; the Insurance Department takes complaints
Expect friction on: It bites in maintenance, when the pills start
The trap: For a Connecticut-regulated policy covered by the rule, oral anticancer medicine must use a cost-sharing basis no less favorable than covered intravenous anticancer treatment. This does not guarantee the same price for a pill and an infusion, formulary coverage or a fixed dollar cap.
Where I read this
- Connecticut Insurance Department Bulletin HC-70-10 — oral anticancer medication parity — Connecticut Insurance Department, read September 10, 2026
- Connecticut Insurance Department — health care bulletins index — Connecticut Insurance Department, read September 10, 2026